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1. Introduction 
1.1. High-yield facts 
 Central line insertion is a very common procedure in critical care settings, and is 
associated with infectious complications such as local colonisation and bloodstream 
infection which leads to bacteremia and sepsis. 
 Causative microorganisms are commonly missed on blood cultures, so that empiric 
therapy must be started in absence of a known pathogen. 
 Diagnosis is based on clinical suspicion and microbiological confirmation by means of 
local and blood cultures (quantitative or semiquantiative). 
 The mainstay of treatment is a combination of early antibiotic treatment and catheter 
removal with insertion at a new site. 
 Prevention is the cornerstone of catheter-related infections. 
 Multimodular programs (education, surveillance and quality management) and the 
sophistication of catheter-associated devices have shown benefit on CRBSI rate 
reduction. 
 Strategies must be grouped into bundles. 
 CRBSI reduction plans are part of the general ICU quality improvement plan. 
 Team work is crucial to the construction and follow-up of the strategies aimed at 
reducing the infection rate in critically-ill patients. 
2. Epidemiology of catheter related bloodstream infections 
Central lines are inserted on a routine basis in critical care settings, for IV fluid 
administration, vasoactive medication infusions and monitoring purposes. As there has 
been worldwide expansion of intensive care facilities in the last few decades, the insertion of 
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central catheters has increased exponentially. Unfortunately, this procedure carries a risk of 
morbidity that includes local and bloodstream infections, which translates into higher 
healthcare costs and eventually into mortality1-3.  
The incidence of catheter-related bloodstream infections (CRBSI) varies widely among 
different healthcare institutions, ranging between 2,1 per 1.000 catheter-days for 
peripherally inserted central catheters (PICCs) to 2,7 per 1.000 catheter-days for non-
tunneled central lines4-6. In the US, it has been estimated that approximately 31.000 deaths 
per year are attributable to bloodstream infections7,  representing an  expenditure of about 
$18.000 per CRBSI8. In Spain the rate of CRBSI has been estimated in the range of 2,1 to 3,4 
per 1.000 hospitalized patients9. Tacconelli et al. showed that the incidence of CRBSI varies 
widely among four european countries (France, Germany, Italy and the UK), from 1,12 to 4,2 
per 1.000 catheter days10. Finally in Latin America and Africa incidence of CRBSI is 
unknown. 
3. Pathogenesis 
CRBSI might occur as a result of the entry of pathogenic microorganisms to the bloodstream 
via four different routes11: local insertion site colonisation, catheter hub contamination, 
hematogenous seeding and infusión of contaminated fluids. Attention has been focused on 
the two first routes12-14. The spread of infection from the insertion site has been widely 
recognized as the main cause of CRBSI, and the risk factors related to its development have 
been matter of research during the last two decades. However, hub contamination is 
relevant for long-term tunneled catheters15. CRBSI co-morbidity risk factors identified are 
insertion technique, insertion site, type and frequency of dressing, frequency of 
manipulation, duration of catheterization, number of catheter lumens, local and systemic 
antibiotic use, type of antiseptic solution use and experience of the person in charge of 
catheter care16-19. On the other hand, the presence of renal failure and hemodialysis are 
independent risk factors for CRBSI20-21. 
Several studies have shown that the causative agent of CRBSI sometimes is difficult to 
isolate. However, some series have reported that the most common organisms responsible 
of infection are: coagulase-negative Staphilococcus, Enterococci, gram negative bacteria (Klebsiella 
Pneumoniae and E. Coli) and Candida Albicans22-24. Healthcare personnel and patient skin 
colonization with Staphylococci is common, and is related to CRBSI, whereas C. Albicans 
and C. Parapsilosis may be responsable of infusate contamination.    
The causative microorganisms of CRBSI are able to produce an exopolysaccaride-rich layer 
that adheres to the catheter. This layer supports the formation of a microbial biofilm, that 
allows bacteria to grow on the surface of foreign bodies in contact with bloodflow. This 
situation confers the causative agent some resistance to antibiotic, making necessary catheter 
removal in order to erradicate infection. Soon after catheter insertion, a thrombin sheath is 
formed on the outer and inner surfaces of the device, facilitating adherence of pathogens. 
This sheath is rich in proteins such as fibronectin, fibrinogen, thrombospondin, laminin and 
adhesin25-29. This last protein is an endogenous protein attractive to coagulase negative 
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Staphylococci. Once bacteria are attached to adhesin, biofilm covers the microorganisms 
from the action of immune system and antibiotic action. 
Unfortunately, information regarding the causative agent in a particular case is sometimes 
useless, due to the low rate of positive blood cultures in an ICU population receiving 
antibiotics for diferent reasons30,31. The isolation of a pathogen in blood cultures is a negative 
prognostic factor32, whereas it is useful to verify the appropriateness of empiric therapy, 
which is related to morbidity and mortaity33,34. On the other hand, positive cultures at the 
insertion site do not predict reliably positive blood cultures35. Furthermore, false positive 
cultures may lead to unnecessary anibiotic treatment, prolonged hospital stay36 and 
emergence of resistant species37,38. 
4. Diagnosis 
It has been found that reliability of clinical findings in CRBSI are not enough to diagnose the 
disease due to their por performance as diagnostic tests.  Fever, one of the most common 
symptoms, has low specificity, whereas local insertion site inflammatory signs have por 
sensitivity. Remission of systemic inflammatory response after catheter removal is 
suggestive but not diagnostic of CRBSI12,37-39. 
The non-uniformity in definition of criteria to diagnose CRBSI has made difficult to compare 
studies and to issue accurate recommendations regarding diagnosis12,23.  However, with 
surveillance purposes, the Centers for Disease Control (CDC) have established the definition 
of  “laboratory confirmed bloodstream infection” (LCBI)40, consisting in meeting at least one 
of the following criteria: 
 Patient has a recognized pathogen cultured from one or more blood cultures and the 
pathogen is not related to an infection at another site. 
 Patient has fever, chills and/or hypotension as well as positive laboratory cultures from 
two or more blood samples drawn on separate occasions which are not related to 
infection at another site and do not reflect contamonation. 
 Patient < 1 year of age has at least one of the following signs or symptoms: fever, 
hypothermia, apnea, or bradicardia (in addition to the above criteria). 
It is adequate to process only the catheter tip for culture23. Quantitative (positive >102 cfu) 
and semiquantitative (positive >105 cfu)  culture techniques are recommended over 
qualitative cultures41-45. It is recommended to culture every catheter removed due to 
suspicion of infection, but it is not a good practice to send every catheter removed to culture. 
Secretion draining from the insertion site must be cultured23. 
According to the IDSA guidelines for the diagnosis and management of catheter related 
infection23, it is recommended that as long as possible, blood cultures should be drawn prior 
to antibiotic administration. When dealing with blood cultures, contamination is an issue 
that must be taken into consideration. Contamination is significant when blood cultures are 
drawn from a catheter in use, as compared to an adequately obtained sample from a 
peripheral vein46-50. On the other hand, diagnostic accuracy is optimal when quantitative 
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paired blood cultures (concomitant catheter and peripheral) are drawn51,52. In summary, an 
accurate diagnosis of CRBSI can be achieved when clinical signs and symptoms are 
associated with positive local and paired blood cultures that match in microbiological terms.  
5. Management 
Empiric antibiotic treatment is a common practice when dealing with CRBSI. The choice of 
the antimicrobial agent depends on the severity of the systemic illness, the comorbidities, 
the most likely microorganisms and the local resistance profile. The combination of catheter 
removal and early antibiotic treatment have shown to be effective (negative blood cultures) 
in 88% of the cases53. Since methicilin-resistant Staphylococcus Epidermidis is the most 
common pathogen, it is reasonable to use Vancomycin as the first choice. In case of MIC > 2 
μg/mL, alternatives such as daptomycin are valuable. On the other hand, gram negative 
microorganisms (including Pseudomonas Aeruginosa) should be covered in neutropenic or 
severely-ill patients. It is not recommended to use linezolid as empiric treatment23. 
Regarding treatment duration, there is no strong evidence in favor of any recommendation. 
Our experience at Clinica de los Andes (unpublished results) have shown that five days 
from the first negative blood cultures is associated with no relapse and favorable outcomes. 
Femoral vein catheters are more prone to develop CRBSI due to the anatomical area of 
insertion. Furthermore, fungi growth is a common occurrence. This situation warrants 
antifungal empiric therapy in this subset of patients.  
Catheter removal is a mainstay of treatment. However, when an ICU patient with moderate 
disease has fever, the recommendation is to draw blood samples from the device and from a 
peripheral vein before making the decision of removal. Most catheters from suspected cases 
of CRBSI end up being sterile53-54. If there is no other possible source of infection, or the 
patient is severely ill, catheter removal and insertion at a new site are recommended. 
The antibiotic regimen must be “de-escalated” depending on blood and local site culture 
results in order to limit the probability of emergence of resistant species. At our institution 
we decide to continue the initial antibiotic depending on clinical response over the 
antibiogram. If the patient is not improving, then the sensitivity tests are taken into account 
to chang the antimicrobial agent. 
6. Prevention: strategies and bundles 
Significant efforts have been made at different levels in order to reduce the incidence of 
CRBSI in intensive care units55-61. Most of the initiatives have focused on preventive 
aspects62-65, as evidence has shown that educational programs as well as multifactorial 
model implementation are effective62-72.   
During the last decade, several studies have investigated different strategies aimed at 
reducing CRBSI by means of prevention73. Most of the studies demonstrate benefit derived 
from multimodule programs including education, surveillance and quality management, 
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and from the development of devices (such as catheter biomaterial and locks, dressings and 
antiseptic solutions). 
The catheter insertion conditions are critical for the development of infections derived from 
the device. The current recommendation includes the use of a long sleeve gown, surgical 
cap, face mask, sterile gloves and large sterile sheets that completely cover the patient74. 
Hand hygiene should be the standard practice, but compliance by health care professionals 
is still poor. In an attempt to enhance compliance, hand rubbing with an alcoholic solution 
might be as good as hand washing75. Chlorhexidine, for example, has shown a better 
antiseptic performance as compared to regular povidone iodine solutions76. However, 
povidone iodine is preferred in some ICUs, especially in the developing world, due to its 
low cost and because of the low bacterial and fungal resistance development77. In this case, 
the povidone iodine solution must remain in contact with the skin for at least one minute in 
order to be effective76. 
The site of insertion of the catheter also influences the infection rate. In general terms, we 
can say that internal jugular approach is associated with a higher risk of CRBSI but a lower 
risk of mechanical complications such as pneumothorax. Conversely subclavian insertion 
requires more expertise but has a significant lower association with infection2. A higher 
infection rate is seen in the femoral approach. Thus, the subclavian approach must be 
preferred, especially for catheters expected to remain in place for more than 7 days78. 
Femoral catheters must be avoided unless the mechanical complication risks of the 
subclavian and jugular approaches are prohibitive 79.   
Numerous studies have shown that catheter replacement on a scheduled basis does not reduce 
CRBSI in ICU80-82. In fact, the 2011 CDC guidelines argue against this practice83. However, 
guidewire exchange to prevent CRBSI is not recommended84-86. Nonetheless, Riveros recently 
showed that in a medical ICU, with a high average length of stay, the central catheter exchange 
scheduled on the eighth day was superior to the a change guided by signs of infection87. In that 
study, 315 catheters (163 patients), were analyzed. Significant catheter colonization rates 
(RR=0,4 CI 95%: 0,1-0,9 p<0,01) and catheter-related sepsis were significantly lower in the 
scheduled change group (RR=0,4 CI 95%: 0,1-0,97 p=0,05). Those findings allow for possibility 
of scheduled catheter change in selected long-term medical ICU patients. However, further 
research is needed before clear-cut recommendations may be issued. 
Transparent and gauze dressings are supposed to be part of ICU general protocols, but their 
use is not systematically adopted in routine practice88. A randomized controlled trial 
reported a reduction from 1,3 to 0,4 catheter-days (hazard rate 0,24 95% CI 0,09-0,65) in 
CRBSI with the use of chlorhexidine-impregnated dressings89. Impregnated catheters have 
been extensively studied but have not been universally used. Despite the theoretical 
advantage of antibiotic-coated catheters, in a meta-analysis, Walder demonstrated that anti-
infective effectiveness of chlorhexidine-sulfadiazine coatings is time-dependent, showing 
good anti-microbial activity for the first week only90. However, the Evidence-based Practice 
in Infection Control (EPIC) in the UK, recommends the use of impregnated catheters in 
adults who require the device for one to three weeks91. 
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As stated above, the approach to CRBSI is multimodal. Recently, a lot of information has 
emerged from studies worldwide, regarding changing practices in ICU. These studies use 
the concept of the “bundle”, which includes a definition of objectives such as training92-94, 
insertion and catheter care. Simulation training, in addition to improving technical skills in 
catheter insertion, allows the resident and physician to easily comply with guidelines and 
checklists95. This technique has shown a significant decrease in CRBSI ranging from 71% to 
84%96,97. 
Most bundle initiatives have followed to the Michigan bundle proposed by Provonoust98-105. 
The Michigan bundle includes hand hygiene, use of chlorexidine for skin preparation, use of 
barrier precautions during insertion, a preference for subclavian vein and the removal of 
unnecessary central lines. The bundle was implemented for the Institute for Health 
Improvement in the US as part of the 5 million lives campaign106 and is considered a 
standard of care. The bundls per se is not capable of controlling CRBSI, so that observation 
and follow-up are mandatory for a prevention strategy to be successful. Riveros et al 
showed that the implementation of the bundles must be accompanied by a strong ICU 
quality management program, which ought to have solid foundations in terms of goal 
definition, follow-up, information system, education and improvement plans107. The 
institution of these plan at different health care centers has produced reports of experiences 
with impressive results66. Finally, the educational programs must be sustained over time, 
and in order to do so, involvement of ICU staff in the construction and follow-up stages of 
the process is crucial and has been able to keep CRBSI low107.  
Additional measures to prevent CRBSI include administration sets replacement, including 
secondary sets and add-on devices, between 96 hours and 7 days108-112, use of central venous 
catheters coated with chlorhexidine and silver sulfadiazine to reduce device 
colonization113,114, and heparin locks impregnated with antibiotics115-117. 
In conclusion, CRBSI has become more challenging in light of the exponential growth of the 
critical care patient population worldwide. In order to cope with these changes, ICU 
healthcare and administrative personnel must work as a team to achieve the goals of a 
quality plan focused on infection control. The different strategies evidence-based strategies 
must be part of a bundle, and must be followed on a routine basis as part of improvement 
plans. 
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